BrightSpring Health Services, Inc. Common Stock Q3 2025 Earnings Recap

BTSG Q3 2025 October 29, 2025

Get alerts when BTSG reports next quarter

BrightSpring Health Services delivered strong third-quarter results, with revenue growth of 28% and adjusted EBITDA up 37% year-over-year, driven by robust performance in its Pharmacy Solutions segment.

Earnings Per Share Beat

$0.30 vs $0.26 est.

+13.9% surprise

Revenue Beat

3334106000 vs 3165325000 est.

+5.3% surprise

Market Reaction

1-Day +0.15%

5-Day -1.5%

30-Day +1.74%

See BTSG alongside your other holdings

Add to your portfolio — free

Key Takeaways

Total revenue reached $3.3 billion, with Pharmacy Solutions revenue growing 31% year-over-year to $3.0 billion.
Adjusted EBITDA amounted to $160 million, reflecting an EBITDA margin expansion of 30 basis points to 4.8%.
Cash flow from operations exceeded $100 million, with leverage reduced to 3.3x, exceeding prior expectations.
Full-year adjusted EBITDA guidance increased to a range of $605 million to $615 million, up from previous forecasts.
Quality and patient satisfaction scores remained high across service lines, supporting continued operational execution and growth.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit BTSG on AllInvestView.

Next Q1 2026